Literature DB >> 19050058

Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.

Jeesuk Yu1, Andrea K Steck, Sunanda Babu, Liping Yu, Dongmei Miao, Kim McFann, John Hutton, George S Eisenbarth, Georgeanna Klingensmith.   

Abstract

CONTEXT: There is controversy as to whether type 2 diabetes genetic susceptibility contributes to type 1 diabetes, and it is not known what proportion of islet autoantibody-negative new onset subjects have type 2 diabetes risk alleles.
OBJECTIVES: We designed this study to evaluate whether two type 2 diabetes-associated single nucleotide polymorphisms (SNPs) of transcription factor 7-like 2 (TCF7L2) gene are associated with the development of islet autoantibody-negative diabetes vs. islet autoantibody-positive diabetes in young patients and whether these SNPs are associated with specific clinical phenotypes.
DESIGN: Autoantibody against glutamic acid decarboxylase 65, islet cell antibody 512bdc (form of IA-2), insulin, ZnT8 transporter, and cytoplasmic islet cell antibody were assayed in patients with new onset diabetes seen at the Barbara Davis Center using sera obtained within 2 wk of diagnosis. We genotyped two noncoding variants in the TCF7L2 gene, rs12255372 and rs7903146, in diabetic subjects and normal controls.
RESULTS: A total of 140 patients (15.7%) were negative for all islet autoantibodies among 893 subjects less than age 25 at the onset of diabetes. The allele and genotype frequencies of two SNPs showed that these are associated (odds ratio up to 4) with the development of diabetes in the autoantibody-negative diabetic cohort, but not in the autoantibody-positive diabetic cohort.
CONCLUSION: TCF7L2 type 2 diabetes susceptibility alleles are associated with islet autoantibody-negative but not autoantibody-positive new onset diabetes in young patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050058      PMCID: PMC2646512          DOI: 10.1210/jc.2007-2694

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta.

Authors:  Fenghua Yi; Patricia L Brubaker; Tianru Jin
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

2.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.

Authors:  Laura J Scott; Lori L Bonnycastle; Cristen J Willer; Andrew G Sprau; Anne U Jackson; Narisu Narisu; William L Duren; Peter S Chines; Heather M Stringham; Michael R Erdos; Timo T Valle; Jaakko Tuomilehto; Richard N Bergman; Karen L Mohlke; Francis S Collins; Michael Boehnke
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

4.  Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men.

Authors:  Cuilin Zhang; Lu Qi; David J Hunter; James B Meigs; JoAnn E Manson; Rob M van Dam; Frank B Hu
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

6.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.

Authors:  L Yu; D T Robles; N Abiru; P Kaur; M Rewers; K Kelemen; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Antiislet autoantibodies usually develop sequentially rather than simultaneously.

Authors:  L Yu; M Rewers; R Gianani; E Kawasaki; Y Zhang; C Verge; P Chase; G Klingensmith; H Erlich; J Norris; G S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

8.  Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.

Authors:  D Schatz; J Krischer; G Horne; W Riley; R Spillar; J Silverstein; W Winter; A Muir; D Derovanesian; S Shah
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children.

Authors:  C L Roth; A Hinney; T Reinehr; F Schreiner; T T Nguyen; T Müller; C Scholl; J Woelfle; A Karpushova; H Schäfer; M M Nöthen; J Hebebrand
Journal:  Horm Metab Res       Date:  2008-06-10       Impact factor: 2.936

10.  Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.

Authors:  Christopher J Groves; Eleftheria Zeggini; Jayne Minton; Timothy M Frayling; Michael N Weedon; Nigel W Rayner; Graham A Hitman; Mark Walker; Steven Wiltshire; Andrew T Hattersley; Mark I McCarthy
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

View more
  5 in total

1.  Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth.

Authors:  D Dabelea; L M Dolan; R D'Agostino; A M Hernandez; J B McAteer; R F Hamman; E J Mayer-Davis; S Marcovina; J M Lawrence; C Pihoker; J C Florez
Journal:  Diabetologia       Date:  2010-11-26       Impact factor: 10.122

2.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

3.  Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes.

Authors:  Maria J Redondo; Jesse Muniz; Luisa M Rodriguez; Dinakar Iyer; Fariba Vaziri-Sani; Morey W Haymond; Christiane S Hampe; Michael L Metzker; Struan F A Grant; Ashok Balasubramanyam
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-06

4.  Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.

Authors:  Gisela Geoghegan; Judith Simcox; Marcus M Seldin; Timothy J Parnell; Chris Stubben; Steven Just; Lori Begaye; Aldons J Lusis; Claudio J Villanueva
Journal:  Mol Metab       Date:  2019-03-14       Impact factor: 7.422

5.  TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes.

Authors:  Maria J Redondo; Susan Geyer; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John Wentworth; Ping Xu; Alberto Pugliese
Journal:  Diabetes Care       Date:  2017-10-12       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.